This episode features Dr. Piper, a Senior Research Engineer at Neurable, a company making waves in the neurotechnology world by developing user-friendly BCIs. Dr. Piper's background is a unique blend of theoretical and experimental neuroscience, complemented by his expertise as a data scientist. He's passionate about creating BCIs for a variety of applications, recognizing the vast potential for real-time interventions in mental health and human behavior. In this episode, we discuss Dr. Piper's 14 years in the industry, his thoughts on the advent of AI and ML models to help advance BCI technology, and the potential of Neurotechnology to be the next big tech industry. Tune in to hear Dr. Piper's perspective on the advent of BCIs, their impact on our understanding of the brain, and how we may observe an increase in their reliance in the very near future. Coming Soon!

This episode features Dr. Shriya Srinivasan, a pioneer in Neurotechnology and bioengineering. As an assistant professor at Harvard and the head of the BIONIC Lab, she's leading the charge in neural control, rehabilitation, and development of novel solutions to neuroscientific problems through an engineering lens. Dr. Srinivasan's groundbreaking work further includes her doctoral work at MIT's Biomechatronics Lab, where she developed novel neural interfaces and surgical paradigms for amputation – work that has already been translated to human use. She also pioneered optogenetic stimulation strategies for neural regeneration. From her award-winning inventions (including the Delsys Prize and the Lemelson-MIT Prize) to her recognition by Forbes and MIT Technology Review as a top innovator, Dr. Srinivasan's accomplishments speak for themselves. Dr. Srinivasan firmly believes in the ideology of effectively translating lab research into usable products and technology by patients to have real-world and widespread impact. In this episode we will be discussing Dr. Srinivasan's insights on the potential of neurotechnology, the future neuroprosthetics, and why it is essential to conduct research with the goal of developing a usable end-product for patients.

Currently at Harvard University, Dr. Mitragotri is the Hiller Professor of Bioengineering, along with a Core Faculty Member at the Wyss Institute. Focused on drug delivery, his research has advanced fundamental understanding of biological barriers and has led to the development of new materials, technologies, and treatments for various ailments including diabetes, cancer, skin diseases, multiple sclerosis, and infections, among others. Many of his inventions have advanced to clinical technologies and a number of start-up companies. At the same time, the fundamental knowledge developed through his research has advanced the understanding of the biology of barriers in the human body. Prof. An incredible visionary, Dr. Mitragotri, shares his insights on Silicon Synapses. We talk about his journey, his thoughts, and his expectations for the future of biomaterials, biotechnology, and more. He also offers an expert view on how these technologies have far-reaching impacts in developing neurological therapeutics, and we discuss the implications of the industry for the future. Stay Tuned! Coming Soon!